{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:30:01Z","timestamp":1781047801373,"version":"3.54.1"},"reference-count":16,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"unspecified","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Veteran Affairs Canada"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,12,15]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Major haemorrhage is the leading cause of preventable death in trauma, and prehospital blood transfusion may improve survival and outcomes for patients with prolonged out-of-hospital times. Globally, there is increasing interest in the use of whole blood in the prehospital environment, with randomised controlled trials ongoing. However, the results of these studies may not be generalisable to the longer out-of-hospital times seen in the Canadian trauma environment. The aim of this trial is to determine the feasibility of performing a randomised clinical trial evaluating the use of leukocyte-reduced whole blood transfusion compared with component blood transfusion in the Canadian prehospital environment. The secondary objective is to explore whether whole blood transfusion is better in reducing the proportion of patients who die or require massive transfusion within 24 hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a multi-centre, open-label, randomised controlled feasibility trial. Patients aged 16 years or older will be eligible if they have suffered a major traumatic haemorrhage, are attended by the provincial air ambulance service and require a prehospital blood transfusion. The primary outcome is feasibility as measured by the following metrics: proportion of patients enrolled with full data collection, proportion of patients who received at least one prehospital transfusion prior to arriving at the receiving trauma centre, proportion of patients who completed transfusion of all assigned blood units, number of patients unable to be enrolled due to lack of whole blood availability and number of whole blood units produced for the study that were wasted or expired. The secondary outcome is a composite outcome of death (all-cause mortality) or receipt of massive transfusion (receipt of 10 units of blood or more) within the first 24 hours from randomisation. We plan to recruit 60 patients, with an anticipated post-randomisation exclusion of ~10 patients for traumatic cardiac arrest or who do not meet eligibility criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Provincial ethics approval was obtained (Clinical Trials Ontario REB ID: CTO-4921). An opt-out consent model will be employed for participants. The SWiFT Canada trial will recruit 60 patients through the provincial air ambulance organisation in Ontario who are transported to one of the six participating lead trauma centres. It will investigate the feasibility of a pre-hospital transfusion clinical trial in Canada to compare the effectiveness of whole blood compared with component blood therapy in a future definitive trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06495294\">NCT06495294<\/jats:ext-link>\n                      (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06495294\">https:\/\/clinicaltrials.gov\/study\/NCT06495294<\/jats:ext-link>\n                      ), Clinical Trials Ontario: CTO-4921.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108570","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:30:21Z","timestamp":1767205821000},"page":"e108570","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Study protocol for a pilot randomised controlled trial assessing prehospital whole blood versus component therapy in traumatic haemorrhage: SWiFT Canada (study of whole blood in frontline trauma)"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06495294","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yulia","family":"Lin","sequence":"first","affiliation":[{"name":"Laboratory Medicine & Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Peddle","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Western University, London, Ontario, Canada"},{"name":"Ornge, Mississauga, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Queen\u2019s University, Kingston, Ontario, Canada"},{"name":"Sunnybrook Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Beckett","sequence":"additional","affiliation":[{"name":"Trauma and Acute Care Surgery, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, Ontario, Canada"},{"name":"Division of General Surgery, Department of Surgery, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-9676","authenticated-orcid":false,"given":"Luis Teodoro","family":"da Luz","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Drennan","sequence":"additional","affiliation":[{"name":"Ornge, Mississauga, Ontario, Canada"},{"name":"Sunnybrook Research Institute, Toronto, Ontario, Canada"},{"name":"Division of Emergency Medicine, Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"FIRST60, St Michael\u2019s Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Pavenski","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Laboratory Medicine, St Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Mack","sequence":"additional","affiliation":[{"name":"Transfusion Medicine and Hematology, Royal Victoria Hospital\/McGill University Health Center, Ottawa, Ontario, Canada"},{"name":"Canadian Blood Services, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McGowan","sequence":"additional","affiliation":[{"name":"FIRST60, St Michael\u2019s Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvareh","family":"Ahghari","sequence":"additional","affiliation":[{"name":"Ornge, Mississauga, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-0421","authenticated-orcid":false,"given":"Jason","family":"Smith","sequence":"additional","affiliation":[{"name":"Emergency Department, University Hospitals Plymouth NHS Trust, Plymouth, UK"},{"name":"Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-9768","authenticated-orcid":false,"given":"Laura","family":"Green","sequence":"additional","affiliation":[{"name":"Components, NHS Blood and Transplant, London, UK"},{"name":"Haematology, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D G","family":"Keown-Stoneman","sequence":"additional","affiliation":[{"name":"Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2872-0643","authenticated-orcid":false,"given":"Brodie","family":"Nolan","sequence":"additional","affiliation":[{"name":"Ornge, Mississauga, Ontario, Canada"},{"name":"FIRST60, St Michael\u2019s Hospital Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada"},{"name":"Division of Emergency Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Emergency Medicine, St Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026010703491392000_15.12.e108570.1","unstructured":"Statistics Canada . Injuries in Canada: insights from the Canadian community health survey. 2011. Available: https:\/\/www.statcan.gc.ca\/pub\/82-624-x\/2011001\/article\/11506-eng.htm"},{"key":"2026010703491392000_15.12.e108570.2","unstructured":"Statistics Canada . Leading causes of death. 2011. Available: https:\/\/www.statcan.gc.ca\/pub\/82-625-x\/2014001\/article\/11896\/c-g\/c-g01-eng.htm"},{"key":"2026010703491392000_15.12.e108570.3","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-0987-5","article-title":"Quantifying the healthcare costs of treating severely bleeding major trauma patients: a national study for England","volume":"19","author":"Campbell","year":"2015","journal-title":"Crit Care"},{"key":"2026010703491392000_15.12.e108570.4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tmrv.2020.08.003","article-title":"Cold-Stored Platelets: Review of Studies in Humans","volume":"34","author":"Mack","year":"2020","journal-title":"Transfus Med Rev"},{"key":"2026010703491392000_15.12.e108570.5","article-title":"Impact of Transfused Citrate on Pathophysiology in Massive Transfusion","volume":"5","author":"Schriner","year":"2023","journal-title":"Crit Care Explor"},{"key":"2026010703491392000_15.12.e108570.6","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2019.5085","article-title":"Association of Prehospital Plasma Transfusion With Survival in Trauma Patients With Hemorrhagic Shock When Transport Times Are Longer Than 20 Minutes: A Post Hoc Analysis of the PAMPer and COMBAT Clinical Trials","volume":"155","author":"Pusateri","year":"2020","journal-title":"JAMA Surg"},{"key":"2026010703491392000_15.12.e108570.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802345"},{"key":"2026010703491392000_15.12.e108570.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31553-8"},{"key":"2026010703491392000_15.12.e108570.9","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2352-3026(22)00040-0","article-title":"Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"9","author":"Crombie","year":"2022","journal-title":"Lancet Haematol"},{"key":"2026010703491392000_15.12.e108570.10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23619","article-title":"Prehospital Lyophilized Plasma Transfusion for Trauma-Induced Coagulopathy in Patients at Risk for Hemorrhagic Shock: A Randomized Clinical Trial","volume":"5","author":"Jost","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026010703491392000_15.12.e108570.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.resplu.2022.100357","article-title":"A descriptive analysis of the Canadian prehospital and transport transfusion (CAN-PATT) network","volume":"13","author":"Greene","year":"2023","journal-title":"Resusc Plus"},{"key":"2026010703491392000_15.12.e108570.12","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2019-209040"},{"key":"2026010703491392000_15.12.e108570.13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.injury.2020.10.095","article-title":"Effectiveness and safety of whole blood compared to balanced blood components in resuscitation of hemorrhaging trauma patients - A systematic review","volume":"52","author":"Malkin","year":"2021","journal-title":"Injury"},{"key":"2026010703491392000_15.12.e108570.14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/SLA.0000000000003324","article-title":"Prehospital Blood Product and Crystalloid Resuscitation in the Severely Injured Patient: A Secondary Analysis of the Prehospital Air Medical Plasma Trial","volume":"273","author":"Guyette","year":"2019","journal-title":"Ann Surg"},{"key":"2026010703491392000_15.12.e108570.15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/TA.0000000000002485","article-title":"Prehospital plasma in injured patients is associated with survival principally in blunt injury: Results from two randomized prehospital plasma trials","volume":"88","author":"Reitz","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"key":"2026010703491392000_15.12.e108570.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-023-07711-4","article-title":"The SWiFT trial (Study of Whole Blood in Frontline Trauma)-the clinical and cost effectiveness of pre-hospital whole blood versus standard care in patients with life-threatening traumatic haemorrhage: study protocol for a multi-centre randomised controlled trial","volume":"24","author":"Smith","year":"2023","journal-title":"Trials"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:53:33Z","timestamp":1767786813000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":16,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,31]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-108570"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108570","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}